Abstract
Three new angucycline-type C-glycosides, grincamycins LāN (1ā3), together with the known rabelomycin (4), moromycin B (5), fridamycin D (6), saquayamycin B1 (7), actinomycin X2 (8), and actinomycin D (9), were isolated from the culture of the soil-derived Streptomyces sp. XZHG99T collected from Color desert, Dengpa District, Tibet. The structures of 1ā3 were established by detailed analyses of comprehensive spectroscopic data. Compounds 1ā9 exhibited significant cytotoxicity against a panel of human cancer cell lines A549, H157, MCF7, MDA-MB-231, and HepG2, while 4, 8, and 9 showed decent antibacterial activity against Mycobacterium smegmatis and Staphylococcus aureus.
Similar content being viewed by others
Introduction
Antimicrobial resistance (AMR) has become a major threat to the global public health especially in developing countries and it is anticipated to be responsible for 10 million death cases every year and a reduction of 2 to 3.5% in Gross Domestic Product (GDP) by 2050 [1]. Therefore, the development of new types of antibiotics against microbe-related diseases remains an urgent requirement. Among all antibiotic-producing microbes, the Streptomyces species are considered to be the most important resource and account for the production of 50ā55% known antibiotics [2, 3]. Angucyclines and actinomycins are two classes of important antibiotics produced by Streptomyces sp., with a broad spectrum of biological properties especially anticancer and antibacterial activities [4,5,6,7]. Angucyclines are characterized in the tetracyclic benz[a]anthracene core and most of them exist as O- or C- glycosides in nature. Actinomycins are a family of chromopeptide lactones, and as the most well-known member of them, actinomycin D has been widely used in clinic as an anti-tumor drug for the treatment of childhood rhabdomyosarcoma and Wilmsā tumor [5, 6]. Meanwhile, actinomycin D also exhibited excellent activity against gram-positive bacteria [5, 6].
As a continuation of our effort to discover new antibacterial agents from actinomycetes based on a bioassay-guided strategy, the Streptomyces sp. XZHG99T from the soil sample collected from Color desert, Dengpa District, Tibet (29Ā°66ā² N, 84Ā°55ā² E) showed well inhibitory activity against Staphylococcus aureu. Our investigation on the crude extract led to the isolation and identification of three new angucycline-type derivatives grincamycins LāN (1ā3), four structurally related co-metabolites including rabelomycin (4) [8, 9], moromycin B (5) [10], fridamycin D (6) [11] and saquayamycin B1 (7) [12], and two actinomycin analogs actinomycin X2 (8) [5] and actinomycin D (9) [5] (Fig.Ā 1). Grincamycin L was the first example of angucycline family having a rhodinosyl C-glycoside linkage at C-9, implying the likely participation of a specific glycosyltransferase in the biosynthetic process. Herein we reported the isolation, structure elucidation and bioactivity of compounds 1ā9.
Results and discussion
Grincamycin L (1) was isolated as a yellow powder, and the molecular formula was determined to be C31H30O10 based on the HR-ESIMS ion at m/z 561.1764 [MāāāH]ā(calcd for C31H29O10, 561.1766). An anthraquinone skeleton was suggested by the maximal UV absorption at 210, 265, and 471ānm, the conjugated carbonyl 13C signals at Ī“ 188.2 and 187.7, as well as the significantly downfield shifted hydroxyl 1H signals at 13.14 and 13.08 due to OH bonding [13]. Analysis of HMBC correlations (Fig.Ā 2) from H-12 to C-1, C-11, C-4a, and C-5a, H-13 to C-2, C-3, and C-4, H-4 to C-4a and C-5, and H-2 to C-1 and C-12a, along with three aromatic protons (Ī“H 7.88, d, 7.8āHz; 7.93, d, 7.8āHz; 8.49, s), revealed that 1 had a linear tetracyclic anthraquinone aglycone as grincamycins E [14] and G [15]. Meanwhile, two doublet methyl signals (Ī“H 1.38 & 1.40) and two anomeric methine signals (Ī“H 4.85 & 5.34; Ī“C 73.3 & 95.1) indicated the presence of two sugars in 1. The 1Hā1H COSY correlations across H-1ā to H3-6ā spin coupling fragment and HMBC correlation from H-5ā to C-1ā revealed a rhodinose moiety, while 1Hā1H COSY correlations of H-2ā with H-1ā and H-3ā, and H-5ā with H3-6ā, as well as HMBC correlations from H-2ā and H3-6ā to C-4ā, and H-1ā to C-5ā, enabled the assembly of an aculose moiety (Fig.Ā 2). The HMBC correlation from H-1ā to C-4ā established the disaccharide fragment as aculose-(1āāā4)-rhodinose, while the C-glycosyl bond between C-9 and C-1ā was supported by the HMBC correlations from H-1ā to C-8, C-9, and C-10. The coupling constants of J1ā,2ā (11.1āHz) and J1ā,2ā (3.5āHz) implied the relative configurations of the two anomeric carbons were Ī² for rhodinose and Ī± for aculose, respectively [12]. The NOESY correlations from H-1ā² to H-5ā² and H-1ā³ to H-4ā² further confirmed the relative configurations of the disaccharide part as shown (Fig.Ā 2). The configuration of C-3 was considered to be consistent with that of N05WA963C [13] on the basis of excellent NMR data comparison, which was further supported by the proposed biosynthetic relation with the known co-metabolites as described later. Although aculose and rhodinose are usual sugar moieties in anthraquinone family, rhodinosyl C-glycoside at C-9 was reported for the first time.
Grincamycin M (2) was obtained as a yellow powder, and the molecular formula of C32H32O11 was deduced from HR-ESIMS analysis (m/z 593.2026 [Mā+āH]+, calcd for 593.2017) and NMR data. The 1H and 13C NMR data (TableĀ 1) of 2 showed high similarity to those of 5 with the only difference attributable to the appearance of a methoxy group (Ī“H 4.04, Ī“C 56.6) in 2 instead of the aromatic proton (H-5) in 5, which was further confirmed by the remarkably downfield shifted C-5 signal (Ī“C 160.8) and the HMBC correlations from the methoxy protons and H-4 to C-5 (Fig.Ā 3). It is also worth to note that H2-4 in 5 was resolved as a singlet signal while geminal coupling was observed for H2-4 in 2, which could be caused by the change of chemical environment around H2-4 (Supplementary material, TableĀ S1). Moreover, the structure and C-3 configuration was determined by the consistent NMR data of 2 with 5 and with N05WA963A [13] which had the same aglycone as 2, as well as biogenetic consideration (Fig.Ā 4) [4].
Grincamycin N (3) was obtained as a dark-red powder with the UV maximal absorption at 265 and 497ānm. The molecular formula of 3 was suggested as C31H28O10 according to the HR-ESIMS ion at m/z 559.1600 ([MāāāH]ā, calcd for C31H27O10, 559.1610). Detailed analysis of 1H and 13C NNR data (TableĀ 2) of 3 implied a linear C-glycosylated tetracenequinone skeleton as galtamycin B [16], while the only difference was attributable to the disaccharide side chain at C-9. As with 2, the sugar moiety of 3 was also assigned to be an Ī±-cinerulose B-(1āāā4, 2āāā3)-Ī²-olivose unit based on decent comparison between the NMR data of the two co-metabolites, which was further corroborated by careful examination of 2D NMR correlations (Supplementary material, Figs. S19āS22). Particularly, the location of 10-OH was established by its HMBC correlations to C-9, C-10 and C-10a. Although no HMBC correlations of 5-OH were observed, its dramatic downfield chemical shift (Ī“H 15.06, brs), due to intramolecular hydrogen bonding with C-6 ketone, enabled its assignment as shown. The structure of 3 was thus characterized.
With seven angucycline analogs (1ā7) in hand, we were able to propose a common biogenesis for these co-metabolites (Fig.Ā 4). These angucyclines, belonging to the polyketide family, were apparently originated from the acetate biosynthetic pathway. The key intermediate involved could be the well-known UWM6 as clearly described previously [17]. A shunt product tetrangomycin from UWM6 [17] would yield moromycin (5) upon glycosylation and also produce 2 via methoxylation and glycosylation, while fridamycin D (6) could be obtained from tetrangomycin by BaeyerāVilliger oxidation, hydrolysis and glycosylation. Rabelomycin (4) could be easily produced from UWM6 through simple dehydration and isomerization, and a putative intermediate (I) from UWM6 [17] would afford saquayamycin B1 (7) via addition of the sugar moiety. Another important shunt intermediate (II) could be furnished from UWM6 as reported previously [18], and compounds 1 and 3 would derive from (II) via glycosylation and aromatization followed by glycosylation, respectively.
Compounds 1ā9 were screened against a panel of human cancer cell lines A549, H157, MCF7, MDA-MB-231, and HepG2, and all the isolates exhibited significant cytotoxicity with IC50 values ranging from 0.09ānM to 17.30āĪ¼M (TableĀ 3). Compounds 1ā5 and 8ā9 were also evaluated for their antimicrobial activity against two gram-positive strains Mycobacterium smegmatis ATCC 607 and Staphylococcus aureus ATCC 25923, two gram-negative strains Escherichia coli ATCC 8739 and Pseudomonas aeruginosa ATCC 9027 and a fungus Candida albicans ATCC10231 (6 and 7 were not tested owing to limited samples). Only compounds 4, 8, and 9 showed antibacterial activity against the two gram-positive strains M. smegmatis and S. aureus with IC50 values from 0.12 to 23.1āĪ¼M (TableĀ 3).
Experimental section
General experimental procedures
NMR spectra were acquired on a Bruker Avance DRX600 NMR spectrometer (Bruker BioSpin AG, FƤllanden, Switzerland) with residual solvent peaks as references (CDCl3: Ī“H 7.26, Ī“C 77.16; pyridine-d5: Ī“H 8.71/7.55/7.18, Ī“C 149.7/135.3/123.3). Optical rotations were measured on a Rudolph VI polarimeter (Rudolph Research Analytical, Hackettstown, USA) with a 10ācm length cell. UV spectra were obtained on a Shimadzu UV-2600 spectrophotometer (Shimadzu, Kyoto, Japan) with 1ācm pathway cell. HR-ESIMS data were acquired on an Agilent 6545 Q-TOF mass spectrometer (Agilent Technologies Inc., Waldbronn, Germany). Semi-preparative HPLC separations were carried out on an Agilent 1260 series (Agilent Technologies Inc., Waldbronn, Germany) using an Agilent Zorbax SB-C18 column (250Ć9.4āmm, 5āĪ¼m). Column chromatography (CC) was performed on Silica gel (200ā300 mesh, Yantai Jiangyou Silica Gel Development Co., Yantai, China) and Sephadex LH-20 gel (GE Healthcare Bio-Sciences AB, Uppsala, Sweden). All solvents used for CC were of analytical grade (Tianjin Fuyu Fine Chemical Co. Ltd., Tianjin, China) and solvents used for HPLC were of HPLC grade (Oceanpak Alexative Chemical Ltd., Goteborg, Sweden).
Biological material
The actinomycete XZHG99T strain was isolated from a soil sample collected from Color desert, Dengpa District, Tibet Autonomous Region, China (29Ā°66ā² N, 84Ā°55ā² E). Comparison of the 16S rRNA sequence of XZHG99T strain with the data from GenBank database (98.42% similarity to S. albiflavescens KCTC 29196T and 98.14% similarity to S. rungchingensis KCTC 29503T), in combination with the morphological traits, revealed that it might represent a new species of the genus Streptomyces. The BLAST sequenced data had been deposited at GenBank (accession no. MG272441). The strain was deposited in CGMCC center, Institute of Microbiology, Chinese Academy of Sciences.
Fermentation and extraction
Although the Streptomyces sp. XZHG99T showed well inhibitory activity against Staphylococcus aureu, HPLC analysis of the crude extract cultured in DS medium showed poor compound diversity. Therefore, different agents were tried to enrich the metabolites from Streptomyces sp. XZHG99T, and DS medium with 3% sea salt was found to yield more metabolites with better antimicrobial activity (Figs. S26āS27).
The Streptomyces sp. XZHG99T was inoculated in 500āmL Erlenmeyer flasks containing 150āmL DS medium (0.5% soluble starch, 0.03% casein, 0.2% KNO3, 0.2% K2HPO4 3H2O, 0.005% MgSO4 7H2O, 0.002% CaCO3, and 0.001% FeSO4 7H2O) at 30āĀ°C on a rotary shaker at 140ārpm for 2 days as seed cultures. Then each of the seed cultures (10āmL) was inoculated into autoclaved 500āmL Erlenmeyer flasks containing 150āmL DS medium described above but containing 3% sea salt. The flasks were incubated at 30āĀ°C for 7 days on a rotary shaker (140ārpm).
The total 40āL fermentation broth was harvested and filtered to give filtrate and mycelia. The filtrate was extracted with an equal volume EtOAc three times, while the mycelia were extracted with 3.0āL 80% acetone three times. The acetone extract was evaporated under reduced pressure to afford an aqueous solution which was then extracted with EtOAc. The two organic layers were combined and dried to give a crude gum (9.8āg).
Isolation and purification
The whole EtOAc extract (9.8āg) was fractionated by a silica gel CC eluting with step gradient CH2Cl2-MeOH (v/v 100:0 to 0:100) to give seven fractions (Fr.1āFr.7) based on TLC and HPLC analysis. Fr.3 (1.9āg) was repeatedly separated by silica gel CC with step gradient CH2Cl2-(CH3)2CO (v/v 100:0 to 0:100) and divided into six subfractions (Fr.3-1āFr.3-6). Fr.3-3 (221.4āmg) was subjected to MPLC with an ODS column eluting with step gradient MeOH-H2O (v/v 20:80 to 0:100) to give three subfractions (Fr.3-3-1āFr.3-3-3) and Fr.3-3-2 (36.8āmg) was further purified by HPLC eluting with MeOH-H2O-AcOH (v/v/v 95:5:0.05, 3.0āmLāminā1) to yield 3 (tRā=ā13.6āmin, 5.2āmg); Fr.3-4 (150.2āmg) was divided by Sephadex LH-20 CC eluting with MeOH-CH2Cl2 (v/v 1:1) and then purified by HPLC eluting with MeCN-H2O (v/v 70:30, 3.0āmLāminā1) to afford 1 (tRā=ā27.3āmin, 2.3āmg); Fr.3-5 (314.8āmg) was also fractionated by Sephadex LH-20 CC eluting with MeOH-CH2Cl2 (v/v 1:1) to obtain four subfractions (Fr.3-5-1āFr.3-5-4) and Fr.3-5-2 (56.8āmg) was purified by HPLC eluting with MeOH-H2O (v/v 77:23, 3.0āmLāminā1) to yield 7 (tRā=ā8.3āmin, 0.6āmg), 5 (tRā=ā11.5āmin, 1.3āmg), and 2 (tRā=ā14.6āmin, 2.9āmg), while Fr.3-5-4 (9.3āmg) was purified by HPLC eluting with MeOH-H2O-AcOH (v/v/v 68:32:0.05, 3.0āmLāminā1) to yield 4 (tRā=ā16.6āmin, 2.2āmg). Fr.5 (567.4āmg) was first subjected to Sephadex LH-20 CC eluting with MeOH and then isolated by HPLC eluting with MeOH-H2O-AcOH (v/v/v 85:15:0.05, 3.0āmLāmin-1) to yield 8 (tRā=ā11.8āmin, 7.2āmg) and 9 (tRā=ā14.9āmin, 20.2āmg). Fr.6-2 (7.5āmg) obtained from Fr.6 (189.1āmg) via Sephadex LH-20 CC eluting with MeOH was further purified by HPLC eluting with MeOH-H2O-AcOH (v/v/v 85:15:0.05, 3.0āmLāminā1) to give 6 (tRā=ā16.3āmin, 0.8āmg).
Grincamycin L (1). Yellow powder; [Ī±]21D 65.1 (c 0.1, CHCl3); UV (MeOH) Ī»max (log Īµ) 210 (3.77), 265 (3.25), 471 (2.45) nm; 1H and 13C NMR data, TableĀ 1; IR (KBr) Ī½max 3457, 2931, 1698, 1636, 1420, 1237, 1045, 797ācmā1; (ā)-HR-ESIMS m/z [MāāāH]ā 561.1764 (calcd for C31H29O10, 561.1766).
Grincamycin M (2). Pale yellow powder; [Ī±]21D 4.5 (c 0.18, CHCl3); UV (MeOH) Ī»max (log Īµ) 223 (3.64), 274 (3.00), 390 (2.02) nm; 1H and 13C NMR data, TableĀ 1; IR (KBr) Ī½max 3448, 1698, 1627, 1556, 1429, 1362, 1278, 1107ācmā1; (ā+ā)-HR-ESIMS m/z 593.2026 [Mā+āH]+ (calcd for C32H33O11, 593.2017).
Grincamycin N (3). Dark-red powder; [Ī±]21D 12.5 (c 0.04, MeOH); UV (MeOH) Ī»max (log Īµ) 265 (5.04), 497.0 (4.40) nm; 1H and 13C NMR data, TableĀ 2; IR (KBr) Ī½max 3448, 2931, 1733, 1614, 1575, 1435, 1390, 1260, 1097, 1027, 905ācmā1; (ā)-HR-ESIMS m/z 559.1600 [MāāāH]ā (calcd for C31H27O10, 559.1610).
Antimicrobial assay
The antimicrobial activity of compounds 1ā5 and 8ā9 was assayed against the gram-positive strains M. smegmatis ATCC 607 and S. aureus ATCC 25923, gram-negative strains E. coli ATCC 8739 and P. aeruginosa ATCC 9027 and fungus C. albicans ATCC10231, by the two-fold serial dilution method in 96-well microplates as described previously [19]. Penicillin was used as positive control in the current assay.
Cytotoxic assay
The cytotoxicity of compounds 1ā9 was evaluated toward A549, H157, MCF7, MDA-MB-231, and HepG2 cell lines using the SRB method as described previously [20], and vinorelbine was used as positive control.
References
O'Neill J. Review on Antimicrobial Resistance. Antimicrobial Resistance: tacking a crisis for the health and wealth of nations. 2014.
Subramani R, Aalbersberg W. Marine actinomycetes: an ongoing source of novel bioactive metabolites. Microbiol Res. 2012;167:571ā80.
Bentley SD et al. Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature. 2002;417:141ā7.
Rohr J, Thiericke R. Angucycline group antibiotics. Nat Prod Rep. 1992;9:103ā37.
Wang D et al. Identification, bioactivity, and productivity of actinomycins from the marine-derived Streptomyces heliomycini. Front Microbiol. 2017;8:1147.
Rathod BB, Korasapati R, Sripadi P, Shetty PR. Novel actinomycin group compound from newly isolated Streptomyces sp. RAB12: isolation, characterization, and evaluation of antimicrobial potential. Appl Microbiol Biot. 2018;10:1241ā50.
Kharel MK et al. Angucyclines: biosynthesis, mode-of-action, new natural products, and synthesis. Nat Prod Rep. 2012;29:264ā325.
Liu WC et al. Isolation, characterization, and structure of rabelomycin, a new antibiotic. J Antibiot. 1970;23:437ā41.
Zhu L et al. Identification of the function of gene lndM2 encoding a bifunctional oxygenase-reductase involved in the biosynthesis of the antitumor antibiotic landomycin E by Streptomyces globisporus1912 supports the originally assigned structure for landomycinone. J Org Chem. 2005;70:631ā8.
Abdelfattah MS, Kharel MK, Hitron JA, Baig I, Rohr J. Moromycins A and B, isolation and structure elucidation of C-glycosylangucycline-type antibiotics from Streptomyces sp. KY002. J Nat Prod. 2008;71:1569ā73.
Maskey RP, Helmke E, Laatsch H. Himalomycin A and B: isolation and structure elucidation of new fridamycin type antibiotics from a marine Streptomyces isolate. J Antibiot. 2003;56:942ā9.
Shaaban KA, Ahmed TA, Leggas M, Rohr J. Saquayamycins G-K cytotoxic angucyclines from Streptomyces sp. including two analogues bearing the aminosugar rednose. J Nat Prod. 2012;75:1383ā92.
Ren X et al. Three novel members of angucycline group from Streptomyces sp. N05WA963. J Antibiot. 2011;64:339ā43.
Huang H et al. Cytotoxic angucycline class glycosides from the deep sea actinomycete Streptomyces lusitanus SCSIO LR32. J Nat Prod. 2012;75:202ā8.
Zhu X et al. Cytotoxic rearranged angucycline glycosides from deep sea-derived Streptomyces lusitanus SCSIO LR32. J Antibiot. 2017;70:819ā22.
Antal N et al. Retymicin, galtamycin B, saquayamycin Z and ribofuranosyllumichrome, novel secondary metabolites from Micromonospora sp. TĆ¼ 6368 II. Structure elucidation. J Antibiot. 2005;58:103ā10.
Salem SM, Weidenbach S, Rohr J. Two cooperative glycosyltransferases are responsible for the sugar diversity of saquayamycins isolated from Streptomyces sp. KY 40-1. ACS Chem Biol. 2017;12:2529ā34.
Zhang Y et al. Identification of the grincamycin gene cluster unveils divergent roles for GcnQ in different hosts, tailoring the l-Rhodinose moiety. Org Lett. 2013;15:3254ā7.
Wang P et al. Phenolic bisabolane sesquiterpenoids from a Thai mangrove endophytic fungus, Aspergillus sp. xy02. Fitoterapia. 2018;127:322ā7.
Ge D et al. Phosphorylation and nuclear translocation of integrin Ī²4 induced by a chemical small molecule contribute to apoptosis in vascular endothelial cells. Apoptosis. 2013;18:1120ā31.
Acknowledgements
We acknowledge the financial support from National Natural Science Foundation of China (Nos. 41506148 & 81673527), Natural Science Foundation of Shandong Province (Nos. BS2015HZ005 & JQ201721), Primary Research and Development Plan of Shandong Province (2016GSF121018), Shandong Provincial Natural Science Joint Found with Universities and Scientific Research Institutes (ZR2018LC001), the Young Taishan Scholars Program (tsqn20161037), and Shandong Talents Team Cultivation Plan of University Preponderant Discipline (No. 10027).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Bao, J., He, F., Li, Y. et al. Cytotoxic antibiotic angucyclines and actinomycins from the Streptomyces sp. XZHG99T. J Antibiot 71, 1018ā1024 (2018). https://doi.org/10.1038/s41429-018-0096-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41429-018-0096-1
This article is cited by
-
Diversity and antimicrobial activities of culturable actinomycetes from Odontotermes formosanus (Blattaria: Termitidae)
BMC Microbiology (2022)
-
Pyomelanin produced by Streptomyces sp. ZL-24 and its protective effects against SH-SY5Y cells injury induced by hydrogen peroxide
Scientific Reports (2021)
-
Streptomyces sp SM01 isolated from Indian soil produces a novel antibiotic picolinamycin effective against multi drug resistant bacterial strains
Scientific Reports (2020)